Hikal Ltd
HIKAL
Company Profile
Business description
Hikal Ltd manufactures chemical intermediates, specialty chemicals, active pharmaceutical ingredients, and contract research activities. Its products are distributed to the pharmaceutical, biotech, agrochemical, and specialty chemical industries. Its segments include Crop Protection and Pharmaceuticals. The majority of the revenue is derived from the pharmaceutical segment.
Contact
Great Eastern Chambers
6th Floor, Sector 11, CBD Belapur
Navi MumbaiMH400 614
INDT: +91 2262770299
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
3,595
Stocks News & Analysis
stocks
Anglo American strikes deal to create a new copper giant
We are surprised that Teck agreed to the merger on these terms, and wouldn’t be surprised if there is a twist in the tale.
stocks
The ‘other’ AI chip behemoth that might just be getting started
The magnitude of growth at Broadcom continues to astound us.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,071.40 | 9.10 | -0.10% |
| CAC 40 | 7,810.65 | 49.33 | 0.64% |
| DAX 40 | 23,660.15 | 27.20 | 0.12% |
| Dow JONES (US) | 46,044.96 | 554.04 | 1.22% |
| FTSE 100 | 9,286.58 | 61.19 | 0.66% |
| HKSE | 26,086.32 | 113.94 | -0.43% |
| NASDAQ | 22,012.09 | 126.03 | 0.58% |
| Nikkei 225 | 44,372.50 | 534.83 | 1.22% |
| NZX 50 Index | 13,229.15 | 47.09 | -0.35% |
| S&P 500 | 6,577.87 | 45.83 | 0.70% |
| S&P/ASX 200 | 8,805.00 | 8.80 | -0.10% |
| SSE Composite Index | 3,875.31 | 63.09 | 1.65% |